US EditionDrug Relieves Fatigue in Long-Covid Patients in Study
Summary by Berliner-sonntagsblatt.de
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
A drug called BC007 has led to significant relief of fatigue symptoms in long-term COVID patients in a study at the University Hospital Erlangen. The research team led by Bettina Hohberger from the Department of Ophthalmology announced this on Friday. The study involved 30 patients suffering from persistent fatigue after a coronavirus infection. Participants initially received either the drug or a placebo, switching after a few weeks. BC007 neut…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
